Additional studies in which we more precisely
define the mechanisms of resistance and growth in an individual's tumor with genomic sequencing, and other means, will be important to maximize the ability to target all the critical pathways to achieve greater success.»
My studies
of cancer genomes have led to characterization
of multiple pediatric and adult tumor types, to development
of methods that identify and characterize changes in genomic heterogeneity, to
defining acquired
resistance mechanisms to targeted therapies and to designing novel, personalized vaccines for individual patients.